{
  "compound": "CBD",
  "condition": "ARTHRITIS",
  "effect_size": "N/A (safety study)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:ARTHRITIS_OBSERVATIONAL_011",
  "participants": "847 arthritis patients using CBD long-term (\u226536 months)",
  "year": 2021,
  "notes": "Long-Term Cannabidiol Safety in Arthritis: 36-Month Pharmacovigilance Study",
  "confidence": "medium",
  "abstract": "Excellent long-term tolerability; minimal tolerance development (dose increase <15% over 36 months); sustained efficacy maintained in 72%"
}